Citigroup Inc. reaffirmed their buy rating on shares of Bayer AG (FRA:BAYN) in a research report sent to investors on Friday morning.

Other equities research analysts have also recently issued reports about the stock. S&P Global Inc. set a €120.00 ($126.32) price target on shares of Bayer AG and gave the company a buy rating in a research report on Tuesday, September 20th. Nord/LB set a €112.00 ($117.89) price target on shares of Bayer AG and gave the company a buy rating in a research report on Wednesday, October 26th. Bankhaus Lampe set a €103.00 ($108.42) price target on shares of Bayer AG and gave the company a buy rating in a research report on Thursday, November 3rd. Societe Generale set a €105.00 ($110.53) price target on shares of Bayer AG and gave the company a neutral rating in a research report on Thursday, September 15th. Finally, DZ Bank AG reissued a neutral rating on shares of Bayer AG in a research report on Wednesday, September 14th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company’s stock. Bayer AG has a consensus rating of Hold and a consensus price target of €109.68 ($115.45).

Shares of Bayer AG (FRA:BAYN) opened at 101.50 on Friday. Bayer AG has a 1-year low of €83.87 and a 1-year high of €112.11. The stock’s 50 day moving average is €94.71 and its 200 day moving average is €93.05. The stock has a market capitalization of €83.94 billion and a price-to-earnings ratio of 17.90.

WARNING: “Bayer AG’s (BAYN) Buy Rating Reiterated at Citigroup Inc.” was first published by Watch List News and is the propert of of Watch List News. If you are accessing this report on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The original version of this report can be read at http://www.watchlistnews.com/bayer-ags-bayn-buy-rating-reiterated-at-citigroup-inc/1055513.html.

About Bayer AG

.

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with Analyst Ratings Network's FREE daily email newsletter.